{
  "id": 2399909,
  "title": "FTC Files Amicus Brief to Protect Competition in Biologic Drug Markets",
  "url": "https://urgent.news/2026/08/21/ftc-files-amicus-brief-to-protect-competition-in-biologic-drug-markets",
  "topic": "business",
  "section": "Business",
  "published": "2026-08-21T12:00:00.000Z",
  "source": {
    "name": "FTC Competition",
    "slug": "ftc-competition",
    "url": "https://www.ftc.gov/news-events/news/press-releases/2026/08/ftc-files-amicus-brief-protect-competition-biologic-drug-markets"
  },
  "original_language": "en",
  "account": null,
  "summary": "The Federal Trade Commission filed an amicus brief in an antitrust case alleging that drug manufacturer Amgen illegally acquired exclusive rights to patent applications that it shaped to cover Enbrel—a drug used to treat rheumatoid arthritis and other inflammatory conditions—allowing Amgen to extend its monopoly over the biologic drug. As part of its efforts to ensure Americans have greater…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}